REGISTERED NUMBER: 12161862 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2025

for

IRIS HEALTH SOLUTIONS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Ms A Clark

P A Purver

REGISTERED OFFICE:

c/o MGB Accountants - Suite 22

Trym Lodge, 1 Henbury Road

Westbury-on-Trym

Bristol

BS9 3HQ

REGISTERED NUMBER:

12161862 (England and Wales)

ACCOUNTANTS:

Mitchell Glanville (Bristol) Limited

c/o MGB Accountants - Suite 22

Trym Lodge, 1 Henbury Road

Westbury-on-Trym

Bristol

BS9 3HQ

FIXED ASSETS

Intangible assets

4

24,454

86,437

Tangible assets

5

-

536

24,454

86,973

CURRENT ASSETS

Debtors

6

431,101

383,126

Cash at bank

9,432

5,355

440,533

388,481

CREDITORS

Amounts falling due within one year

7

399,565

252,859

NET CURRENT ASSETS

40,968

135,622

TOTAL ASSETS LESS CURRENT LIABILITIES

65,422

222,595

CREDITORS

Amounts falling due after more than one year

8

799,162

799,919

NET LIABILITIES

(733,740

)

(577,324

)

CAPITAL AND RESERVES

Called up share capital

9

2,000

2,000

Share premium

1,098,000

1,098,000

Retained earnings

(1,833,740

)

(1,677,324

)

SHAREHOLDERS' FUNDS

(733,740

)

(577,324

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 3 November 2025 and were signed on its behalf by:

P A Purver - Director

1.	STATUTORY INFORMATION

iRIS Health Solutions Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of three years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of three years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

33% on cost

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 2 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

Goodwill

assets

Totals

£

£

£

COST

At 1 April 2024

and 31 March 2025

99,900

1,185,951

1,285,851

AMORTISATION

At 1 April 2024

99,900

1,099,514

1,199,414

Charge for year

-

61,983

61,983

At 31 March 2025

99,900

1,161,497

1,261,397

NET BOOK VALUE

At 31 March 2025

-

24,454

24,454

At 31 March 2024

-

86,437

86,437

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 April 2024

and 31 March 2025

2,474

DEPRECIATION

At 1 April 2024

1,938

Charge for year

536

At 31 March 2025

2,474

NET BOOK VALUE

At 31 March 2025

-

At 31 March 2024

536

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

72,053

59,600

Amounts owed by group undertakings

26,043

26,543

Other debtors

333,005

296,983

431,101

383,126

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Bank loans and overdrafts

9,600

2,400

Trade creditors

67,382

30,459

Taxation and social security

12,519

2,591

Other creditors

310,064

217,409

399,565

252,859

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025

2024

£

£

Bank loans

11,461

20,945

Amounts owed to group undertakings

787,701

778,974

799,162

799,919

9.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

1,000

Ordinary A Shares

1

1,000

1,000

1,000

Ordinary B Shares

1

1,000

1,000

2,000

2,000

10.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with other group companies.

At the year end, the company was owed £26,043 (2024: £26,543) by TWM E8 Limited, a controlling party of iRIS Health Solutions Limited.

11.	ULTIMATE CONTROLLING PARTY

The company is under the control of TWM E8 Limited (50%), Philip Purver (25%) and Alexandra Clark (25%).